EP on EP Episode 76: Intersection of EP and CHF with Clyde W. Yancy, MD, MSci-Eric N. Prystowsky, MD, FHRS, sits down with Silvia G Priori, MD, PhD, to discuss gene therapy for the treatment of catecholaminergic polymorphic ventricular tachycardia (CPVT).

Eric N. Prystowsky, MD, FHRS, sits down with Silvia G Priori, MD, PhD, to discuss gene therapy for the treatment of catecholaminergic polymorphic ventricular tachycardia (CPVT).

Back to course

Video Transcription

Video Summary

In this segment of EP on EP, Eric Vrstovsky interviews Clyde Yancy, Chief of Cardiology at Northwestern Medicine. They discuss the intersectionality of arrhythmias and heart failure and the need for co-management. They highlight the similarities in risk factors for atrial fibrillation (AFib) and heart failure, emphasizing the importance of prevention strategies. They also discuss the need for more research and trials to understand the optimal management of patients with both conditions. They touch on topics such as tachyarrhythmia-mediated cardiomyopathy and the use of ICDs in heart failure patients. They acknowledge the challenges in determining who truly benefits from certain therapies and the need for better predictors. Overall, they emphasize the importance of ongoing research and collaboration between disciplines to improve patient outcomes.

Keywords

arrhythmias

heart failure

co-management

prevention strategies

patient outcomes